SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001231
Filing Date
2022-05-10
Accepted
2022-05-10 08:45:48
Documents
46
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clrb-20220331x10q.htm   iXBRL 10-Q 775316
2 EX-3.1 clrb-20220331xex3d1.htm EX-3.1 9378
3 EX-4.1 clrb-20220331xex4d1.htm EX-4.1 13368
4 EX-31.1 clrb-20220331xex31d1.htm EX-31.1 11408
5 EX-31.2 clrb-20220331xex31d2.htm EX-31.2 11406
6 EX-32.1 clrb-20220331xex32d1.htm EX-32.1 8967
  Complete submission text file 0001410578-22-001231.txt   3461513

Data Files

Seq Description Document Type Size
7 EX-101.SCH clrb-20220331.xsd EX-101.SCH 27669
8 EX-101.CAL clrb-20220331_cal.xml EX-101.CAL 24566
9 EX-101.DEF clrb-20220331_def.xml EX-101.DEF 137724
10 EX-101.LAB clrb-20220331_lab.xml EX-101.LAB 225310
11 EX-101.PRE clrb-20220331_pre.xml EX-101.PRE 193389
40 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20220331x10q_htm.xml XML 463294
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 22907538
SIC: 2834 Pharmaceutical Preparations